CSL Limited (ASX:CSL) Share Price, Buyback and 2026 Outlook: Latest News and Forecasts as at 5 December 2025
CSL shares closed at A$182.43 on 5 December 2025, near multi-year lows after restructuring, a guidance cut, and a delayed vaccines spin-off. The company has repurchased over 2.5 million shares under a new buyback and opened a A$1 billion vaccine and antivenom plant in Melbourne. Market cap stands near A$89 billion, with shares down about 35% over 12 months.